E.G7-OVA-hCD24
Strain Information
Validation Data
Ⅰ.In vitro Expression of E.G7-OVA-hCD24-Luc cell line
The human CD24 protein expression in the E.G7-OVA and E.G7-OVA-hCD24-Luc cells were measured by Flow Cytometry.
Figure 1. hCD24 expression in wild-type E.G7-OVA and E.G7-OVA-hCD24-Luc cell lines
Luciferase activity expression on the E.G7-OVA-hCD24-Luc cell was measured by microplate reader.
Figure 2. Luciferase activity assay of E.G7-OVA-hCD24-Luc cell line
Ⅱ.Characterization of in vivo growth kinetics
To verify whether there is the difference in tumor formation between the E.G7-OVA -hCD24-Luc cell line and the E.G7-OVA cell line, both cells were subcutaneously inoculated into C57BL/6 mice.
Figure 3. Tumor growth curve of E.G7-OVA and E.G7-OVA-hCD24-Luc syngeneic model
Figure 4. Body weight change of E.G7-OVA and E.G7-OVA-hCD24-Luc syngeneic model
Ⅲ. Expression of OVA protein in tumors
To verify the human CD24 protein expression, the tumors were dissected and separated for single cell suspension.
Figure 5. The expression of hCD24 in humanized modified tumors by FACS
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
